Mechanism of telomerase activation by v-Rel and its contribution to transformation

Journal of Virology

Volumn 80, Issue 1, 2006, Pages 281-295

  Hrdličková, Radmila ^a   Nehyba, Jiří ^a   Liss, Andrew S ^a   Bose Jr , Henry R ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TELOMERASE; TELOMERASE INHIBITOR; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LINE; CELL PROTECTION; CELL TRANSFORMATION; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; FIBROBLAST; GENE EXPRESSION; LYMPHOID CELL; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; ONCOGENE PROTEINS V-REL; REACTIVE OXYGEN SPECIES; RNA, NEOPLASM; TELOMERASE; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 33645960991     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.1.281-295.2006     Document Type: Article

References (96)

1. Aggarwal, B. B. 2004. Nuclear factor-κB: the enemy within. Cancer Cell 6:203-208.
2. Akiyama, M., T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson. 2002. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 62:3876-3882.
3. Akiyama, M., T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson. 2003. Nuclear factor-κB p65 mediates tumor necrosis factor α-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 63:18-21.
4. Akiyama, M., O. Yamada, N. Kanda, S. Akita, T. Kawano, T. Ohno, H. Mizoguchi, Y. Eto, K. C. Anderson, and H. Yamada. 2002. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett. 178:187-197.
5. Akiyama, Y., and S. Kato. 1974. Two cell lines from lymphomas of Marek's disease. Biken J. 17:105-116.
6. Alitalo, K., J. M. Bishop, D. H. Smith, E. Y. Chen, W. W. Colby, and A. D. Levinson. 1983. Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc. Natl. Acad. Sci. USA 80:100-104.
7. Baba, T. W., B. P. Giroir, and E. H. Humphries. 1985. Cell lines derived from avian lymphomas exhibit two distinct phenotypes. Virology 144:139-151.
8. Bernard, D., D. Monte, B. Vandenbunder, and C. Abbadie. 2002. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene 21:4392-4402.
9. Bernard, D., B. Quatannens, A. Begue, B. Vandenbunder, and C. Abbadie. 2001. Antiproliferative and antiapoptotic effects of cRel occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res. 61:2656-2664.
10. Beug, H., A. von Kirchbach, G. Döderlein, J.-F. Conscience, and T. Graf. 1979. Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18:375-390.
11. Bharti, A. C., and B. B. Aggarwal. 2002. Nuclear factor-κB and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64:883-888.
12. Blasco, M. A. 2003. Mammalian telomeres and telomerase: why they matter for cancer and aging. Eur. J. Cell Biol. 82:441-446.
13. Blasco, M. A. 2003. Telomeres and cancer: a tale with many endings. Curr. Opin. Genet. Dev. 13:70-76.
14. Blasco, M. A., and W. C. Hahn. 2003. Evolving views of telomerase and cancer. Trends Cell Biol. 13:289-294.
15. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916.
16. Bokoch, G. M., and U. G. Knaus. 2003. NADPH oxidases: not just for leukocytes anymore! Trends Biochem. Sci. 28:502-507.
17. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288.
18. Chen, J.-L., M. A. Blasco, and C. W. Greider. 2000. Secondary structure of vertebrate telomerase RNA. Cell 100:503-514.
19. Colgin, L. M., C. Wilkinson, A. Englezou, A. Killian, M. O. Robinson, and R. R. Reddel. 2000. The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426-432.
20. Cong, Y.-S., W. E. Wright, and J. W. Shay. 2002. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66:407-425.
21. Delany, M. E., and L. M. Daniels. 2004. The chicken telomerase reverse transcriptase (chTERT): molecular and cytogenetic characterization with a comparative analysis. Gene 339:61-69.
22. DeLorbe, W. J., P. A. Luciw, H. M. Goodman, H. E. Varmus, and J. M. Bishop. 1980. Molecular cloning and characterization of avian sarcoma virus circular DNA molecules. J. Virol. 36:50-61.
23. Dimri, G. P., J.-L. Martinez, J. J. L. Jacobs, P. Keblusek, K. Itahana, M. van Lohuizen, J. Campisi, D. E. Wazer, and V. Band. 2002. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62:4736-4745.
24. Ducrest, A.-L., H. Szutorisz, J. Lingner, and M. Nabholz. 2002. Regulation of the human telomerase reverse transcriptase gene. Oncogene 21:541-552.
25. Falchetti, M. L., G. Falcone, E. D'Ambrosio, R. Verna, S. Alemà, and A. Levi. 1999. Induction of telomerase activity in v-myc-transformed avian cells. Oncogene 18:1515-1519.
26. Feng, J., W. D. Funk, S.-S. Wang, S. I. Weinrich, A. A. Avilion, C.-P. Chiu, R. R. Adams, E. Chang, R. C. Allsopp, J. Yu, S. Le, M. D. West, C. B. Harley, W. H. Andrews, C. W. Greider, and B. Villiponteau. 1995. The RNA regulatory elements of the human telomerase. Science 269:1236-1241.
27. Filardo, E. J., M. F. Lee, and E. H. Humphries. 1994. Structural genes, not the LTRs, are the primary determinants of reticuloendotheliosis virus A-induced runting and bursal atrophy. Virology 202:116-128.
28. Forsyth, N. R., W. E. Wright, and J. W. Shay. 2002. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69:188-197.
29. Fragnet, L., M. A. Blasco, W. Klapper, and D. Rasschaert. 2003. The RNA subunit of telomerase is encoded by Marek's disease virus. J. Virol. 77:5985-5996.
30. Franklin, R. B., C.-Y. Kang, K. M.-M. Wan, and H. R. Bose, Jr. 1977. Transformation of chick embryo fibroblasts by reticuloendotheliosis virus. Virology 83:313-321.
31. Gorbunova, V., A. Seluanov, and O. M. Pereira-Smith. 2002. Expression of human telomerase hTERT does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277:38540-38549.
32. Green, R. E., B. P. Lewis, R. T. Hillman, M. Blanchette, L. F. Lareau, A. T. Garnett, D. C. Rio, and S. E. Brenner. 2003. Widespread predicted non-sense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics 19:i118-i121.
33. Hisatomi, H., K. Ohyashiki, J. H. Ohyashiki, K. Nagao, T. Kanamaru, H. Hirata, N. Hibi, and Y. Taukada. 2003. Expression profile of a γ-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 5:193-197.
34. Hiyama, E., and K. Hiyama. 2002. Clinical utility of telomerase in cancer. Oncogene 21:643-649.
35. Hrdličková, R., J. Nehyba, and H. R. Bose, Jr. 2001. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol. Cell. Biol. 21:6369-6386.
36. Hrdličková, R., J. Nehyba, and E. H. Humphries. 1994. v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel. J. Virol. 68:308-319.
37. Kang, S. S., T. Kwon, D. Y. Kwon, and S. I. Do. 1999. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274:13085-13090.
38. Kanzaki, Y., F. Onoue, H. Sakurai, and T. Ide. 2003. Telomerase upregulates expression levels of interleukin (IL)-1α, IL-1β, IL-6, IL-8, and granulocyte-macrophage colony-stimulating factor in normal human fibroblasts. Biochem. Biophys. Res. Commun. 305:150-154.
39. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
40. Killian, A., D. D. L. Bowtell, H. E. Abud, G. R. Hime, D. J. Venter, P. K. Keese, E. L. Duncan, R. R. Reddel, and R. A. Jefferson. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:2011-2019.
41. ink4a, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells. Exp. Cell Res. 272:199-208.
42. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, and J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
43. Kim, N. W., and F. Wu. 1997. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:2595-2597.
44. Klingelhutz, A. J., S. A. Foster, and J. K. McDougall. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82.
45. Kralova, J., A. S. Liss, W. Bargmann, C. Pendleton, J. Varadarajan, E. Ulug, and H. R. Bose, Jr. 2002. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel. J. Virol. 76:11960-11970.
46. Krams, M., B. Hero, F. Berthold, R. Parwaresch, D. Harms, and P. Rudolph. 2003. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am. J. Pathol. 162:1019-1026.
47. Kyo, S., and M. Inoue. 2002. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene 21:688-697.
48. Leber, B., and S. Bacchetti. 1996. Telomeres and telomerase in normal and malignant haematologic cells. Leuk. Lymphoma 24:1-9.
49. Lewis, R. B., J. McClure, B. Rup, D. W. Niesel, R. F. Garry, J. D. Hoelzer, K. Nazerian, and H. R. Bose, Jr. 1981. Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell 25:421-431.
50. Lin, A., and M. Karin. 2003. NF-κB in cancer: a marked target. Semin. Cancer Biol. 13:107-114.
51. Lin, S.-Y., and S. J. Elledge. 2003. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113:881-889.
52. Liu, K., R. J. Hodes, and N. Weng. 2001. Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J. Immunol. 166:4826-4830.
53. Mandal, M., and R. Kumar. 1997. Bcl-2 modulates telomerase activity. J. Biol. Chem. 272:14183-14187.
54. Masutomi, K., and W. C. Hahn. 2003. Telomerase and tumorigenesis. Cancer Lett. 194:163-172.
55. Masutomi, K., E. Y. Yu, S. Khurts, I. Ben-Porath, J. L. Currier, G. B. Metz, M. W. Brooks, S. Kaneko, S. Murakami, J. A. DeCaprio, R. A. Weinberg, S. A. Stewart, and W. C. Hahn. 2003. Telomerase maintains telomere structure in normal human cells. Cell 114:241-253.
56. Misiti, S., S. Nanni, G. Fontemaggi, Y. S. Cong, J. Wen, H. Hirte, G. Piaggio, A. Sacchi, A. Pontecorvi, S. Bacchetti, and A. Farsetti. 2000. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. 20:3764-3771.
57. Moore, B. E., and H. R. Bose, Jr. 1988. Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology 162:377-387.
58. Moscovici, C., N. Zeller, and M. G. Moscovici. 1982. Continuous lines of AMV-transformed nonproducer cells: growth and oncogenic potential in the chick embryo, p. 435-449. In R. F. Revoltella, et al. (ed.), Expression of differentiated functions in cancer cells. Raven Press, New York, N.Y.
59. Nazerian, K., E. A. Stephens, J. M. Sharma, L. M. Lee, M. Gailitis, and R. I. Witter. 1977. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Avian Dis. 21:69-76.
60. Nehyba, J., R. Hrdličková, and E. H. Humphries. 1994. Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation. J. Virol. 68:2039-2050.
61. Okuno, H., T. Suzuki, T. Yoshida, Y. Hashimoto, T. Curran, and H. Iba. 1991. Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene. Oncogene 6:1491-1497.
62. Park, N.-H., W. Guo, H.-R. Kim, M. K. Kang, and N.-H. Park. 2001. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter. Int. J. Oncol. 19:755-761.
63. Perkins, N. D., A. B. Agranoff, E. Pascal, and G. J. Nabel. 1994. An interaction between the DNA-binding domains of RelA (p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14:6570-6583.
64. Perry, P. J., S. M. Gowan, A. P. Reszka, P. Polucci, T. C. Jenkins, L. R. Kelland, and S. Neidle. 1998. 1,4- and 2,6-disubstituted amidoanthracene-9,10- dione derivatives as inhibitors of human telomerase. J. Med. Chem. 41:3253-3260.
65. 64a. Petrenko, O., I. Ischenko, and P. J. Enrietto. 1997. Characterization of changes in gene expression associated with malignant transformation by the NF-κB family member, v-Rel. Oncogene 15:1671-1680.
66. Poremba, C., B. Heine, R. Diallo, A. Heinecke, D. Wai, K. L. Schaefer, Y. Braun, A. Schuck, C. Lanvers, A. Bankfalvi, S. Kneif, J. Torhorst, M. Zuber, O. R. Kochli, F. Mross, H. Dieterich, G. Sauter, H. Stein, F. Fogt, and W. Boecker. 2002. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J. Pathol. 198:181-189.
67. Rahman, R., L. Latonene, and K. G. Wiman. 2004. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene 24:1320-1327.
68. Rao, A., K. Kline, and B. G. Sanders. 1990. Immune abnormalities in avian erythroblastosis virus-infected chickens. Cancer Res. 50:4764-4770.
69. Ren, J.-G., H.-L. Xia, Y.-M. Tian, T. Just, G.-P. Cai, and Y.-R. Dai. 2001. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 488:133-138.
70. Reynolds, A., D. Leake, Q. Boese, S. Scaringe, W. S. Marsball, and A. Khvorova. 2004. Rational siRNA design for RNA interference. Nat. Biotechnol. 22:326-330.
71. Sharma, G. G., A. Gupta, H. Wang, H. Scherthan, S. Dhar, V. Gandhi, G. Iliakis, J. W. Shay, C. S. H. Young, and T. K. Pandita. 2003. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22:131-146.
72. Sharpless, N. E., and R. A. DePinho. 2004. Telomeres, stem cells, senescence, and cancer. J. Clin. Investig. 113:160-168.
73. Shay, J. W., and W. E. Wright. 2005. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 26:867-874.
74. Sif, S., and T. D. Gilmore. 1994. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J. Virol. 68:7131-7138.
75. Smith, L. L., H. A. Coller, and J. M. Roberts. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5:474-479.
76. Stephens, R. M., N. R. Rice, R. R. Hiebsch, H. R. Bose, Jr., and R. V. Gilden. 1983. Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc. Natl. Acad. Sci. USA 80:6229-6233.
77. Stoker, A. W., and M. J. Bissell. 1987. Quantitative immunocytochemical assay for infectious avian retroviruses. J. Gen. Virol. 68:2481-2485.
78. Stone, E. M., K. N. Rothblum, M. C. Alevy, T. M. Kuo, and R. J. Schwartz. 1985. Complete sequence of the chicken glyceraldehyde-3-phosphate dehydrogenase gene. Proc. Natl. Acad. Sci. USA 82:1628-1632.
79. Swanberg, S. E., and M. E. Delany. 2003. Dynamics of telomere erosion in transformed and non-transformed avian cells in vitro. Cytogenet. Genome Res. 102:318-325.
80. Ueda, M. 2000. Telomerase in cutaneous carcinogenesis. J. Dermatol. Sci. 23:37-40.
81. Ulaner, G. A., J. F. Hu, T. H. Vu, L. C. Guidice, and A. R. Hoffman. 1998. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168-4172.
82. Viatour, P., M.-P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30:43-52.
83. von Zglinicki, T. 2002. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27:339-344.
84. von Zglinicki, T., A. Bürkle, and T. B. L. Kirkwood. 2001. Stress, DNA damage and ageing-an integrative approach. Exp. Gerontol. 36:1049-1062.
85. Wang, J., L. Y. Xie, S. Allan, D. Beach, and G. J. Hannon. 1998. Myc activates telomerase. Genes Dev. 12:1769-1774.
86. Watson, D. K., E. P. Reddy, P. H. Duesberg, and T. S. Papas. 1983. Nucleotide sequence analysis of the chicken c-myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, Δ gag-myc. Proc. Natl. Acad. Sci. USA 80:2146-2150.
87. Weng, N. 2002. Regulation of telomerase expression in human lymphocytes. Springer Semin. Immunopathol. 24:23-33.
88. White, D. W., and T. D. Gilmore. 1993. Temperature-sensitive transforming mutants of the v-rel oncogene. J. Virol. 67:6876-6881.
89. Wilhelmsen, K. C., K. Eggleton, and H. M. Temin. 1984. Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J. Virol. 52:172-182.
90. Wright, J. G., and J. W. Christman. 2003. The role of nuclear factor κB in the pathogenesis of pulmonary diseases. Am. J. Respir. Med. 2:211-219.
91. Yi, X., D. M. White, D. L. Aisner, J. A. Baur, W. E. Wright, and J. W. Shay. 2000. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2:433-440.
92. Yin, L., A. K. Hubbard, and C. Giardina. 2000. NF-κB regulates transcription of the mouse telomerase catalytic subunit. J. Biol. Chem. 275:36671-36676.
93. Yokoyama, Y., X. Wan, Y. Takahashi, A. Shinohara, and T. Tamaya. 2001. Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus. Mol. Hum. Reprod. 7:853-857.
94. Yoo, J., S. Y. Park, S. J. Kang, B. K. Kim, S. I. Shim, and C. S. Kang. 2003. Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod. Pathol. 16:700-707.
95. Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter. 2004. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32:W130-W134.
96. Zhang, P., S. L. Chan, W. Fu, M. Mendoza, and M. P. Mattson. 2003. TERT suppresses apoptosis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J. 17:767-769.